Development and manufacture of lentiviral vectors - Scientific guideline

This guideline describes quality aspects that are relevant for lentiviral vectors (LV). It applies to LV intended for ex vivo or in vivo application.

Keywords: Gene therapy medicinal product, lentiviral vector, quality, manufacturing, advanced therapy medicinal products (ATMPs), lentivirus, development

Current effective version

Guideline on development and manufacture of Lentiviral Vectors

AdoptedLegal effective date: 01/11/2005Reference Number: CHMP/BWP/2458/03